In this study, we characterized gene expression of NR4A1–NR4A3 in all the breast cancer subtypes (Basal, Her2, Luminal A, and Luminal B) by using large genomic studies (TCGA and METABRIC). This evidence concerns the gene NR4A1 and breast carcinoma.